Smartleaf Asset Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Hold
5,410
0.02% 539
2026
Q1
$234K Buy
5,410
+3,455
+177% +$155K 0.01% 729
2025
Q4
$62.9K Buy
1,955
+887
+83% +$27.7K ﹤0.01% 1436
2025
Q3
$28.8K Buy
1,068
+442
+71% +$13.4K ﹤0.01% 1657
2025
Q2
$22.5K Buy
626
+298
+91% +$10.3K ﹤0.01% 1501
2025
Q1
$13.2K Sell
328
-22
-6% -$991 ﹤0.01% 1809
2024
Q4
$16.5K Buy
350
+175
+100% +$7.91K ﹤0.01% 1753
2024
Q3
$8.12K Buy
175
+102
+140% +$4.85K ﹤0.01% 1884
2024
Q2
$3.47K Buy
73
+52
+248% +$2.12K ﹤0.01% 1980
2024
Q1
$724 Buy
+21
New +$758 ﹤0.01% 1685

Other funds holding TWST

Smartleaf Asset Management's TWST Position: Q2 2026 in Review

Smartleaf Asset Management held its Twist Bioscience (TWST) position steady in Q2 2026 at 5,410 shares worth $532K. The position accounts for 0.02% of the portfolio, ranked #539.

Smartleaf Asset Management first reported a position in TWST in Q1 2024 and has held it in 10 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Smartleaf Asset Management held 5,410 shares of Twist Bioscience worth $532K as of Q2 2026.
  • Smartleaf Asset Management left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #539 holding.
  • Smartleaf Asset Management first reported a position in Twist Bioscience in Q1 2024 and has held it in 10 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.